Envoya, a Boston-based software company, innovates life-changing solutions through advanced research and technology.
Founded in Boston, Massachusetts, Envoya is a pioneering software company dedicated to revolutionizing gene therapy through advanced biomedical technologies. The company's core mission is to overcome the most significant barrier in gene therapy—its delivery system—by developing polymer-based nanoparticles for targeted delivery. Envoya aims to bring hope and a brighter future to medicine and patients worldwide through its groundbreaking research and innovative technology.
Envoya has attracted notable experts and investors in the biomedical field, contributing to its rapid advancements and credibility. The company's key achievements include the successful development of a distinctive app and significant strides in polymer nanoparticle technology for gene therapy. Envoya's impact is profound, offering life-changing solutions that promise to transform the landscape of medical treatments and improve patient outcomes globally.
